European regulators have granted Medtronic CE mark approval for its SureTune3 deep-brain stimulation software, which gives visualization of lead locations and indicates stimulation level. Medtronic's portfolio of deep-brain stimulation devices in the EU are CE-marked to treat Parkinson's disease, essential tremor, obsessive-compulsive disorder, dystonia and epilepsy.
EU OKs Medtronic's deep-brain stimulation software
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.